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Abstract 
     The plant genus Dalea (Fabaceae) has been found to be prolific in its production of phenolic 
secondary metabolites including flavonoids, isoflavonoids, chalcones, pterocarpans, stilbenes, 
and other biosynthetically related compounds. Biological testing has revealed wide-ranging 
activities for these metabolites in many prior reports. Dalea jamesii has not yet been investigated 
for its chemical content. This study will be conducted with the hypothesis that unique phenolic 
secondary metabolites will be produced in the roots of D. jamesii. It will be of interest to 
determine if the isolated metabolites exhibit biomedically related activities. It will also be of 
interest to investigate whether the phenolic secondary metabolites show any bioactivities.  
     Using various techniques, including vacuum liquid chromatography, Sephadex LH-20 
chromatography, and linear gradient or step gradient chromatography, the secondary metabolites 
from the root portion of D. jamesii will be separated. Thin-layer chromatography (TLC) and 1H 
NMR spectroscopy will be used to combine similar materials for further purification. Structure 
determination of the pure compounds will be accomplished primarily by extensive 1D and 2D 
NMR spectroscopy.
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I. Introduction 
     This research is focused on the isolation and characterization of secondary metabolites 
produced in D. jamesii. This specific plant has not been investigated previously, and a crude 
extract of it revealed promising anticancer activity in its preliminary testing with glioblastoma 
cells in vitro.   
A natural product is a chemical compound that is found in nature, produced by living 
organisms. When natural products are isolated from living organisms, they are synthesized in 
order to be made available in large quantities. One famous example of natural product is taxol 
(paclitaxel), a complex terpenoid compound, which is a drug used in the treatment of breast, 
lung, and ovarian cancer. It was first isolated from the bark of Taxus brevifolia, the Pacific Yew, 
and was later mass produced through processes reliant on plant-derived biosynthesis.1 Similarly, 
aspirin, a drug used for centuries in the treatment of headaches and fever, was found in the bark 
of the willow tree (Salix spp.).2  
Secondary metabolites are small molecules that are not directly involved in the normal 
growth, development, reproduction of the organism, or other primary functions. Rather, they are 
often responsible for health-maintaining processes, such as in plant defense against herbivory.3 
For example, (±)-sanjuanolide, a secondary metabolite isolated from D. frutescens, was found to 
have anti-inflammatory activity, markedly reducing the production of lipopolysaccharide (LPS)-
induced IL-6 and TNF-α with IC20 values of 1.1 and 1.6 μM, respectively.4  
Dalea jamesii (Torr.) Torr. & A. Gray (Fabaceae), commonly known as James’ Prairie 
Clover, is a perennial herb that is predominantly found in dry and rocky plains of the 
southwestern regions of the United States.5 D. jamesii has bright yellow flowers in clusters that 
turn reddish brown as they age (Figure 1).  
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(a)                                                       (b) 
Figure 1.  The whole plant, in flower, D. jamesii collected from Sierra Vista scenic overlook, 
Colorado, in 2017. (a) D. jamesii aerial portions.  (b) D. jamesii aerial and root portion.      
 
 
Figure 2. Core structures of flavonoids, isoflavonoids, chalcones, pterocarpans, and stilbenes.
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It is reasonable to assume that compounds similar to those shown in Figure 2 will be found in our 
investigation of D. jamesii.   
There is a growing body of knowledge from prior investigations of Dalea species. An 
investigation of the roots of D. filiciformis revealed a new pterocarpan, daleformis, the structure 
of which (Figure 3) was determined by interpretation of NMR spectroscopic data and by X-ray 
diffraction analysis. Bioassays revealed daleformis inhibited endothelin-converting enzyme with 
a half maximal inhibitory concentration (IC50) of 9 μM.6 
 
 
Figure 3.  The pterocarpan daleformis was isolated from D. filiciformis. 
 
From the whole plant D. versicolor, a new prenylated isoflavanone, dalversinol A (Figure 4), 
and a number of known phenolic compounds, including prenylated flavanones, a chalcone, a 
pterocarpan, and a stilbene, were isolated. Structures of the purified compounds were determined 
by extensive 1D, and 2D NMR spectroscopy, and high resolution mass spectrometric (HRMS) 
methods. Dalversinol A and three other isolated compounds were found to exhibit direct or 
synergistic activity toward the human pathogens Staphylococcus aureus and Bacillus cereus.7 
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Figure 4.  The prenylated isoflavanone dalversinol A was isolated from D. versicolor. 
D. searlsiae was investigated for its chemical content and from the roots, new prenylated and 
geranylated flavanones, named malheurans, and known flavanones were isolated.8 From the 
aerial portions, known rotenoids and isoflavones, were isolated (Figure 5). Structures of purified 
compounds were determined primarily by extensive 1D- and 2D-NMR spectroscopy. The 
absolute configurations of compounds were assigned using electronic circular dichroism 
spectroscopy. Bioassays revealed significant antimicrobial bioactivity concentrated in the plant 
roots.8  
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Figure 5.  New prenylated and geranylated flavanones, malheurans, isolated from Dalea 
searlsiae. 
 
 Preliminary in vitro assays of the root extract of D. jamesii (tested at 10 mg/mL) caused a 
reduction (<90%) in cell viability of U87MG glioblastoma cells. Specific cell counts are not yet 
available, but this extract was one of six listed as exhibiting relatively potent activity in this 
recent testing. Glioblastoma are malignant brain tumor cells that also colonize niches outside the 
central nervous system (CNS).9 It has high proliferative rate, aggressive invasiveness and 
insensitivity to radiotherapy and chemotherapy, resulting in short patient survival periods. It is 
difficult to inhibit glioblastoma cells because they are heterogeneous, containing various 
populations of cells. As a result, a drug may work for some cells but have no effect on others. 
The tumor grows behind the blood-brain barrier, a highly selective, semipermeable border that 
protects the brain from toxic chemicals. This requires that drugs have certain limited 
characteristics to be able to cross this barrier and reach the tumor.10 The current treatments of 
glioblastoma tumors include surgery, radiation, and chemotherapy with temozolomide, Platinol 
(cisplatin), BiCNU (carmustine), and Gleostine (lomustine). None of these compounds are 
6 
flavonoids or natural products. These treatments can slow the tumor growth but are unlikely to 
eradicate the tumor.11 Another synthetic compound KHS101, a complex heterocyclic amine, has 
showed promising in vivo activity in mice via disruption of mitochondrial respiration.12 
Our prior work has revealed Dalea spp. to be prolific producers of phenolic secondary 
metabolites including flavonoids, isoflavonoids, chalcones, pterocarpans, stilbenes, and other 
biosynthetically related compounds. There have been reports of Dalea compounds with 
antitumor activities. The flavanone 6PP, isolated from D. elegans, showed antitumor activity in a 
rat liver cell line.13 Perhaps similar in action to KHS101, 6PP had disruptive effects on 
mitochondria. Another study showed the chalcone (R)-sanjuanolide, synthesized (R)- 
configuration from the isolated (±)-sanjuanolide from D. frutescens, to have antiproliferative and 
cytotoxic activities, with a half maximal inhibitory concentration (IC50) of 11 ±4 mM and 7 ±3 
mM toward the prostate cancer cell lines PC-3 and DU 145, respectively.14 Therefore, flavonoids 
may have potential for the treatment of glioblastoma and other cancers. 
Dalea spp. are native to geographic regions that, in future years, are expected to see 
increasing frequency and severity of climate-change induced drought and heat; a concern to the 
scientific community because these are regions of relatively high biodiversity.15,16 While only 
several are currently listed as threatened or endangered,5 Dalea spp. are C3 photosynthetic 
plants,17 and are likely to be more susceptible to drought than C4 or CAM photosynthetic plants 
like grasses and cacti, respectively.16,18 
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II. Research Questions & Hypothesis 
Main research question: 
 Are new phenolic secondary metabolites, including flavonoids, isoflavonoids, chalcones, 
pterocarpans, stilbenes, and other biosynthetically related chemotypes, produced in the 
roots of Dalea jamesii?  
Additional questions: 
 Do the phenolic secondary metabolites show antitumor activities? 
 Do the phenolic secondary metabolites show other bioactivities?  
 Are any of the phenolic secondary metabolites new? If known, where were they 
produced? 
 For any new compounds…are there any similar compounds from prior reports? Do they 
have similar functional groups? Is there any similarity in bioactivity?  
Based on previous investigations on Dalea spp., phenolic secondary metabolites of higher 
interest were produced in the roots; therefore, it is hypothesized that phenolic secondary 
metabolites will be produced in the roots of D. jamesii. Also, preliminary testing of the root 
extract exhibited cytotoxic activity to U87MG glioblastoma cells. Therefore, it is hypothesized 
that phenolic secondary metabolites will show antitumor activities.  
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III. Research Plan 
In this research, methods of extraction and chromatography will be used to isolate the 
compounds. The collected D. jamesii was divided into aerial and root portions. Preparation of the 
crude extracts of these was first done on a small scale for biological testing by blending with 
methanol. Preliminary testing of the resulting root extract revealed cytotoxic activity to U87MG 
glioblastoma cells, while the crude extract of the aerial portions did not exhibit any activity. The 
subsequent crude extract was first separated using vacuum liquid chromatography (VLC) over 
silica gel, eluting with varying proportions of hexane, ethyl acetate, dichloromethane, and 
methanol solvents in increasing polarity. Then, VLC fractions will be further separated using 
Sephadex LH-20 chromatography with isocratic elution using 3:1:1 hexane-toluene-methanol. 
Pure methanol will be used as a final wash. Combinations of certain of the resulting fractions 
will be then successively separated by linear gradient or step gradient chromatography over silica 
gel until pure compounds are isolated.  
Thin-layer chromatography (TLC) will be used at each stage of the purification process to 
evaluate the purity and polarity of the compounds in each fraction. Fractions of similar 
composition, according to TLC and, as purity increases, 1H NMR spectroscopy, will be 
combined for further purification. Structure determination of the pure compounds will be 
accomplished primarily by extensive 1D- and 2D-NMR spectroscopy. 
 There are some limitations in this research. First, the lack of certain instrumentation in 
the Chemistry Department is one major limitation. Central Washington University does not have 
an ECD (electronic circular dichroism) spectrometer, for obtaining absolute configuration of 
certain molecules, or a high-resolution mass spectrometer, for supporting the molecular formula 
derived from 
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NMR. Therefore, samples will be sent out to other facilities that obtain these data. When samples 
are sent out, it takes time to get the results back, which is inconvenient.  
The Chemistry Department is awaiting the delivery and installation of a new NMR spectrometer 
at the start of the 2020-21 academic year.  Once this happens, we will have access to important 
methods that were previously unavailable, like NOESY NMR, used for obtaining relative 
configuration. However, there is still uncertainty as to whether the new NMR will be available 
for use prior to my own graduation.  Finally, despite the research mentor’s earnest desire to 
spend more time in the lab with his mentees, he has much less teaching release time (granted by 
the College of the Sciences) than in the past.  
 
Time Table 
Week 1 Grind D. jamesii roots in methanol to prepare crude extraction (already done) 
Week 2 Run vacuum liquid chromatography (VLC) over silica gel, eluting with varying 
portions of hexane, ethyl acetate, dichloromethane, and methanol solvents in 
increasing polarity. 
Week 3 TLC and determine which fractions will be loaded onto Sephadex LH-20. 
Week 4 Run size-exclusion column chromatography (Sephadex LH-20) with isocratic 
elution using 3:1:1 hexane-toluene-methanol. 
Week 5 TLC and determine which fractions will be further purified.  
10 
 
Week 6-8 Linear gradient or step gradient chromatography over silica gel until pure 
compounds are isolated. Thin-layer chromatography (TLC) will be used to 
evaluate the purity and polarity of the compounds in each fraction.  
Week 9, 10 Using NMR spectroscopy, the structures of isolated pure compounds will be 
determined.  
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IV. Results 
A Bruker 400 MHz NMR spectrometer was used exclusively for determining the structure of the 
newly discovered compound LA-1-21-F2. A broadband probe was used in the acquisition of 1H 
NMR data (Figure 6), 13C NMR data (Figure 7), DEPT 90, DEPT 135 and COSY NMR 
experiments.  An inverse probe was used for acquisition of 2D spectra, HSQC, and HMBC 
(Figure 6), experiments. Another compound, LA-1-32-F4, was also isolated and identified as a 
known compound, previously isolated from D. wrightii and named JC-1-13-F2 (Figure 8). 
 
 
Figure 6.  1H NMR assignments and selected HMBC correlations for the isoflavan 
LA-1-21-F2. Key HMBC correlations are represented by red arrows from hydrogen 
nuclei to corresponding carbon nuclei. 
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Figure 7.  13C NMR spectroscopic assignments for the isoflavan LA-1-21-F2. 
 
 
 
Figure 8.  The isoflavan JC-1-13-F2. 
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V. Discussion 
The 1D NMR spectra were predominantly used for initial comparisons of LA-1-21-F2 to 
compounds of our in-house NMR spectroscopic library.  These data also allowed us to identify 
certain sub-structures that are characteristic of metabolites of Dalea spp. The 2D NMR spectra 
were critical for the determination of the overall structure of LA-1-21-F2.  The HSQC and 
HMBC (heteronuclear multiple bond correlation) experiments in particular, helped to establish 
the connectivity between rings B and C, and the placement of methoxy and prenyl substituents of 
ring A (Figure 6). LA-1-21-F2 was found to be a new compound.  The most similar known 
compound (Figure 9) was reported 32 years ago from the tropical tree Diphysa robinioides.19 
 
 
Figure 9.  The most similar known compound to LA-1-21-F2 is (-)-4’-O-methylpreglabridin.19 
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VI. Conclusion 
Two compounds were isolated and identified. LA-1-21-F2 was newly discovered while LA-
1-21-F2 were identified to be identical to a previously discovered compound, JC-1-13-F2. 
Further purification of fractions collected from Sephadex LH-20 chromatography, followed by 
further NMR spectroscopic characterization is needed. The determination of absolute 
configuration of LA-1-21-F2 will be done using electronic circular dichroism spectroscopy 
(ECD). In vitro testing toward the glioblastoma cells will be performed for the pure compound, 
LA-1-21-F2, and all other pure isolates.  
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